High levels of PAI-1 were detected in bronchoalveolar lavage fluid collected from critically ill COVID-19 patients, and impaired fibrinolysis in the lungs may contribute to the in situ deposition of fibrin. The gene discussed is SERPINE1; the disease is COVID-19.